GCIA
MDT icon

Gabelli & Co Investment Advisers’s Medtronic MDT Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,000
Closed -$240K – 258
2024
Q4 		$240K Buy
+3,000
New +$260K 0.04% 183

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Gabelli & Co Investment Advisers's MDT Position: Q1 2025 in Review

Gabelli & Co Investment Advisers sold out of Medtronic (MDT) in Q1 2025, closing a stake of 3,000 shares — an estimated $240K sold.

Gabelli & Co Investment Advisers first reported a position in MDT in Q4 2024 and held it in 1 quarter. The position peaked at $240K in Q4 2024. 2,170 funds tracked by Wall St. Rank hold MDT as of Q1 2025.

  • Gabelli & Co Investment Advisers reported no remaining Medtronic position as of Q1 2025 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 3,000 Medtronic shares in Q1 2025, an estimated $240K.
  • Gabelli & Co Investment Advisers first reported a position in Medtronic in Q4 2024 and held it in 1 quarter.
  • Gabelli & Co Investment Advisers's Medtronic position peaked at $240K in Q4 2024.
  • 2,170 funds tracked by Wall St. Rank held Medtronic as of Q1 2025.

Based on Gabelli & Co Investment Advisers's 13F filing for Q1 2025, filed 14 May 2025.